{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:27:40Z","timestamp":1790767660459,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47257-4","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:35:04Z","timestamp":1776090904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Saikosaponin D and paeoniflorin improve the HCC immune microenvironment via CLCF1\/PD-L1 mediated crosstalk between CAFs and tumor cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Kun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"issue":"Pt 3","key":"47257_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","volume":"86","author":"GP Nagaraju","year":"2022","unstructured":"Nagaraju, G. P., Dariya, B., Kasa, P., Peela, S. & El-Rayes, B. F. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol. 86(Pt 3), 622\u2013632 (2022).","journal-title":"Semin Cancer Biol."},{"issue":"2","key":"47257_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79(2), 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"issue":"4","key":"47257_CR3","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s12072-021-10281-9","volume":"16","author":"YG Chen","year":"2022","unstructured":"Chen, Y. G. et al. The association between metabolic risk factors, nonalcoholic fatty liver disease, and the incidence of liver cancer: a nationwide population-based cohort study. Hepatol. Int. 16(4), 807\u2013816 (2022).","journal-title":"Hepatol. Int."},{"issue":"1","key":"47257_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","volume":"27","author":"P Ganesan","year":"2023","unstructured":"Ganesan, P. & Kulik, L. M. Hepatocellular carcinoma: New developments. Clin. Liver Dis. 27(1), 85\u2013102 (2023).","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"47257_CR5","doi-asserted-by":"publisher","first-page":"e1300","DOI":"10.1002\/ctm2.1300","volume":"13","author":"Z Shi","year":"2023","unstructured":"Shi, Z. et al. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation. Clin. Transl Med. 13(6), e1300 (2023).","journal-title":"Clin. Transl Med."},{"issue":"1","key":"47257_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13046-022-02567-z","volume":"42","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis. J. Exp. Clin. Cancer Res. 42(1), 6 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"47257_CR7","first-page":"62","volume":"1","author":"G Li","year":"2025","unstructured":"Li, G. et al. Breaking boundaries: Chronic diseases and the frontiers of immune microenvironments. Med. Res. 1(1), 62\u2013102 (2025).","journal-title":"Med. Res."},{"issue":"11","key":"47257_CR8","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.3390\/ijms22115801","volume":"22","author":"K Oura","year":"2021","unstructured":"Oura, K., Morishita, A., Tani, J. & Masaki, T. Tumor immune microenvironment and immunosuppressive therapy in hepatocellular carcinoma: A review. Int. J. Mol. Sci. 22(11), 5801 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"47257_CR9","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne, R. & Lujambio, A. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology 77(5), 1773\u20131796 (2023).","journal-title":"Hepatology"},{"issue":"1","key":"47257_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/01635581.2023.2276525","volume":"76","author":"F Zhang","year":"2024","unstructured":"Zhang, F., Zhou, K., Yuan, W. & Sun, K. Radix bupleuri-radix paeoniae alba inhibits the development of hepatocellular carcinoma through activation of the PTEN\/PD-L1 axis within the immune microenvironment. Nutr. Cancer 76(1), 63\u201379 (2024).","journal-title":"Nutr. Cancer"},{"issue":"13","key":"47257_CR11","first-page":"3597","volume":"47","author":"X Zou","year":"2022","unstructured":"Zou, X. et al. [Mechanism of Bupleurum scorzonerifolium and Paeonia lactiflora herbal pair against liver cancer: an exploration based on UPLC-Q-TOF-MS combined with network pharmacology]. Zhongguo Zhong Yao Za Zhi. 47(13), 3597\u20133608 (2022).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"5","key":"47257_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1139\/bcb-2020-0561","volume":"99","author":"L Lin","year":"2021","unstructured":"Lin, L. et al. Saikosaponin-d protects against liver fibrosis by regulating the estrogen receptor-\u03b2\/NLRP3 inflammasome pathway. Biochem. Cell. Biol. 99(5), 666\u2013674 (2021).","journal-title":"Biochem. Cell. Biol."},{"issue":"23","key":"47257_CR13","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.3390\/molecules27238534","volume":"27","author":"X Deng","year":"2022","unstructured":"Deng, X. et al. Paeoniflorin protects against acetaminophen-induced liver injury in mice via JNK signaling pathway. Molecules 27(23), 8534 (2022).","journal-title":"Molecules"},{"issue":"4","key":"47257_CR14","first-page":"3165","volume":"19","author":"H Liu","year":"2020","unstructured":"Liu, H., Zang, L., Zhao, J., Wang, Z. & Li, L. Paeoniflorin inhibits cell viability and invasion of liver cancer cells via inhibition of Skp2. Oncol. Lett. 19(4), 3165\u20133172 (2020).","journal-title":"Oncol. Lett."},{"issue":"8","key":"47257_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/biom11081107","volume":"11","author":"J Lee","year":"2021","unstructured":"Lee, J. et al. Phytochemicals in cancer immune checkpoint inhibitor therapy. Biomolecules 11(8), 1107 (2021).","journal-title":"Biomolecules"},{"key":"47257_CR16","doi-asserted-by":"publisher","first-page":"4724938","DOI":"10.1155\/2021\/4724938","volume":"2021","author":"K Niu","year":"2021","unstructured":"Niu, K. et al. Antitumor effects of paeoniflorin on hippo signaling pathway in gastric cancer cells. J. Oncol. 2021, 4724938 (2021).","journal-title":"J. Oncol."},{"issue":"3","key":"47257_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ptr.7676","volume":"37","author":"LL Chen","year":"2023","unstructured":"Chen, L. L. et al. Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3. Phytother Res. 37(3), 809\u2013819 (2023).","journal-title":"Phytother Res."},{"issue":"5","key":"47257_CR18","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/hep.31792","volume":"73","author":"M Song","year":"2021","unstructured":"Song, M. et al. Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression. Hepatology 73(5), 1717\u20131735 (2021).","journal-title":"Hepatology"},{"issue":"1","key":"47257_CR19","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo, H. et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat. Commun. 13(1), 6619 (2022).","journal-title":"Nat. Commun."},{"key":"47257_CR20","doi-asserted-by":"publisher","first-page":"872380","DOI":"10.3389\/fgene.2022.872380","volume":"13","author":"Z Zeng","year":"2022","unstructured":"Zeng, Z., Zuo, Y., Jin, Y., Peng, Y. & Zhu, X. Identification of extracellular matrix signatures as novel potential prognostic biomarkers in lung adenocarcinoma. Front. Genet. 13, 872380 (2022).","journal-title":"Front. Genet."},{"issue":"33","key":"47257_CR21","doi-asserted-by":"publisher","first-page":"e2305717120","DOI":"10.1073\/pnas.2305717120","volume":"120","author":"M Ding","year":"2023","unstructured":"Ding, M. et al. CLCF1 signaling restrains thermogenesis and disrupts metabolic homeostasis by inhibiting mitochondrial biogenesis in brown adipocytes. Proc. Natl. Acad. Sci. U. S. A. 120(33), e2305717120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"47257_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones, S. A. & Jenkins, B. J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat. Rev. Immunol. 18(12), 773\u2013789 (2018).","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"47257_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang, X. et al. Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol. Cancer. 18(1), 10 (2019).","journal-title":"Mol. Cancer"},{"issue":"5","key":"47257_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer, F. et al. The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell. 38(5), 685-700e688 (2020).","journal-title":"Cancer Cell."},{"key":"47257_CR25","doi-asserted-by":"publisher","first-page":"964442","DOI":"10.3389\/fimmu.2022.964442","volume":"13","author":"Q Tang","year":"2022","unstructured":"Tang, Q. et al. The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front. Immunol. 13, 964442 (2022).","journal-title":"Front. Immunol."},{"key":"47257_CR26","doi-asserted-by":"publisher","first-page":"810832","DOI":"10.3389\/fimmu.2022.810832","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. CLCF1 is a novel potential immune-related target with predictive value for prognosis and immunotherapy response in glioma. Front. Immunol. 13, 810832 (2022).","journal-title":"Front. Immunol."},{"issue":"1","key":"47257_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12964-023-01200-6","volume":"21","author":"B Sun","year":"2023","unstructured":"Sun, B., Lei, X., Cao, M., Li, Y. & Yang, L. Y. Hepatocellular carcinoma cells remodel the pro-metastatic tumour microenvironment through recruitment and activation of fibroblasts via paracrine Egfl7 signaling. Cell. Commun. Signal. 21(1), 180 (2023).","journal-title":"Cell. Commun. Signal."},{"key":"47257_CR28","doi-asserted-by":"publisher","first-page":"116140","DOI":"10.1016\/j.bone.2021.116140","volume":"153","author":"S Yokota","year":"2021","unstructured":"Yokota, S. et al. Cardiotrophin like cytokine factor 1 (CLCF1) alleviates bone loss in osteoporosis mouse models by suppressing osteoclast differentiation through activating interferon signaling and repressing the nuclear factor-\u03baB signaling pathway. Bone 153, 116140 (2021).","journal-title":"Bone"},{"issue":"11","key":"47257_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s11655-018-2985-3","volume":"25","author":"ZF Wang","year":"2019","unstructured":"Wang, Z. F. et al. Paeoniflorin inhibits migration- and invasion-promoting capacities of gastric cancer associated fibroblasts. Chin. J. Integr. Med. 25(11), 837\u2013844 (2019).","journal-title":"Chin. J. Integr. Med."},{"key":"47257_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000340","author":"H Sheng","year":"2020","unstructured":"Sheng, H. et al. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma. J. Immunother. Cancer https:\/\/doi.org\/10.1136\/jitc-2019-000340 (2020).","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"47257_CR31","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1172\/JCI126022","volume":"129","author":"LC Chan","year":"2019","unstructured":"Chan, L. C. et al. IL-6\/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion. J. Clin. Invest. 129(8), 3324\u20133338 (2019).","journal-title":"J. Clin. Invest."},{"key":"47257_CR32","doi-asserted-by":"publisher","first-page":"154766","DOI":"10.1016\/j.phymed.2023.154766","volume":"114","author":"M Huang","year":"2023","unstructured":"Huang, M. et al. Saikosaponin A and D attenuate skeletal muscle atrophy in chronic kidney disease by reducing oxidative stress through activation of PI3K\/AKT\/Nrf2 pathway. Phytomedicine 114, 154766 (2023).","journal-title":"Phytomedicine"},{"issue":"6","key":"47257_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/aps.2016.36","volume":"37","author":"Y Ji","year":"2016","unstructured":"Ji, Y. et al. Paeoniflorin suppresses TGF-\u03b2 mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Acta Pharmacol. Sin. 37(6), 794\u2013804 (2016).","journal-title":"Acta Pharmacol. Sin."},{"issue":"17","key":"47257_CR34","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.3390\/ijms21176122","volume":"21","author":"HS Lee","year":"2020","unstructured":"Lee, H. S. & Jeong, G. S. Chrysophanol mitigates T cell activation by regulating the expression of CD40 ligand in activated T cells. Int. J. Mol. Sci. 21(17), 6122 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"47257_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-019-1161-8","volume":"38","author":"M Shen","year":"2019","unstructured":"Shen, M. et al. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK\/STAT3\/PD-L1 pathway. J. Exp. Clin. Cancer Res. 38(1), 149 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"47257_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4049\/jimmunol.2000763","volume":"207","author":"D Calianese","year":"2021","unstructured":"Calianese, D. et al. Phosphatidylserine-targeting monoclonal antibodies exhibit distinct biochemical and cellular effects on anti-CD3\/CD28-stimulated T cell IFN-\u03b3 and TNF-\u03b1 production. J. Immunol. 207(2), 436\u2013448 (2021).","journal-title":"J. Immunol."},{"issue":"12","key":"47257_CR37","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/s41556-022-01024-5","volume":"24","author":"J Bae","year":"2022","unstructured":"Bae, J. et al. IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8(+) T cells to overcome immunotherapy resistance in cancer. Nat. Cell. Biol. 24(12), 1754\u20131765 (2022).","journal-title":"Nat. Cell. Biol."},{"issue":"3","key":"47257_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41575-019-0229-4","volume":"17","author":"AJ Craig","year":"2020","unstructured":"Craig, A. J., von Felden, J., Garcia-Lezana, T., Sarcognato, S. & Villanueva, A. Tumour evolution in hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 17(3), 139\u2013152 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"47257_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis. Cell. Death Dis. 13(5), 478 (2022).","journal-title":"Cell. Death Dis."},{"issue":"1","key":"47257_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","volume":"9","author":"GQ Zhu","year":"2023","unstructured":"Zhu, G. Q. et al. CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor. Cell. Discov. 9(1), 25 (2023).","journal-title":"Cell. Discov"},{"issue":"4","key":"47257_CR41","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J. Hepatol. 78(4), 770\u2013782 (2023).","journal-title":"J. Hepatol."},{"issue":"3","key":"47257_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000505695","volume":"9","author":"H Deng","year":"2020","unstructured":"Deng, H. et al. Dual vascular endothelial growth factor receptor and fibroblast growth factor receptor inhibition elicits antitumor immunity and enhances programmed cell death-1 checkpoint blockade in hepatocellular carcinoma. Liver Cancer 9(3), 338\u2013357 (2020).","journal-title":"Liver Cancer"},{"key":"47257_CR43","doi-asserted-by":"publisher","first-page":"874589","DOI":"10.3389\/fimmu.2022.874589","volume":"13","author":"Y Pu","year":"2022","unstructured":"Pu, Y. & Ji, Q. Tumor-associated macrophages regulate PD-1\/PD-L1 immunosuppression. Front. Immunol. 13, 874589 (2022).","journal-title":"Front. Immunol."},{"issue":"10","key":"47257_CR44","doi-asserted-by":"publisher","first-page":"16824","DOI":"10.1002\/jcp.28358","volume":"234","author":"A Salmaninejad","year":"2019","unstructured":"Salmaninejad, A. et al. PD-1\/PD-L1 pathway: Basic biology and role in cancer immunotherapy. J. Cell. Physiol. 234(10), 16824\u201316837 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"47257_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13045-022-01242-2","volume":"15","author":"M Wu","year":"2022","unstructured":"Wu, M. et al. Improvement of the anticancer efficacy of PD-1\/PD-L1 blockade via combination therapy and PD-L1 regulation. J. Hematol. Oncol. 15(1), 24 (2022).","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"47257_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan, W. et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol. Cancer. 21(1), 60 (2022).","journal-title":"Mol. Cancer"},{"issue":"11","key":"47257_CR47","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41419-021-04356-6","volume":"12","author":"J Pan","year":"2021","unstructured":"Pan, J. et al. USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1. Cell Death Dis. 12(11), 1051 (2021).","journal-title":"Cell Death Dis."},{"issue":"2","key":"47257_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.gastro.2024.02.025","volume":"167","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. TGF-\u03b21-induced SOX18 elevation promotes hepatocellular carcinoma progression and metastasis through transcriptionally upregulating PD-L1 and CXCL12. Gastroenterology 167(2), 264\u2013280 (2024).","journal-title":"Gastroenterology"},{"key":"47257_CR49","doi-asserted-by":"publisher","first-page":"630970","DOI":"10.3389\/fphar.2021.630970","volume":"12","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Studies on the changes of pharmacokinetics behaviors of phytochemicals and the influence on endogenous metabolites after the combination of Radix bupleuri and Radix paeoniae alba based on multi-component pharmacokinetics and metabolomics. Front. Pharmacol. 12, 630970 (2021).","journal-title":"Front. Pharmacol."},{"issue":"4","key":"47257_CR50","first-page":"1073","volume":"49","author":"L Ding","year":"2024","unstructured":"Ding, L. et al. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297\/PTEN signaling axis]. Zhongguo Zhong Yao Za Zhi. 49(4), 1073\u20131081 (2024).","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"47257_CR51","doi-asserted-by":"publisher","first-page":"115317","DOI":"10.1016\/j.biopha.2023.115317","volume":"166","author":"M Gao","year":"2023","unstructured":"Gao, M., Zhang, D., Jiang, C., Jin, Q. & Zhang, J. Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression. Biomed. Pharmacother. 166, 115317 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"47257_CR52","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3389\/fphar.2019.01039","volume":"10","author":"CY Zhang","year":"2019","unstructured":"Zhang, C. Y. et al. Saikosaponin-d inhibits the hepatoma cells and enhances chemosensitivity through SENP5-dependent inhibition of Gli1 SUMOylation under hypoxia. Front. Pharmacol. 10, 1039 (2019).","journal-title":"Front. Pharmacol."},{"key":"47257_CR53","doi-asserted-by":"publisher","first-page":"117985","DOI":"10.1016\/j.jep.2024.117985","volume":"328","author":"J Sun","year":"2024","unstructured":"Sun, J. et al. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology. J. Ethnopharmacol. 328, 117985 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"47257_CR54","doi-asserted-by":"publisher","first-page":"116539","DOI":"10.1016\/j.jep.2023.116539","volume":"312","author":"S Bi","year":"2023","unstructured":"Bi, S. et al. Preliminary exploration of method for screening efficacy markers compatibility in TCM prescriptions based on Q-markers: Anti-inflammatory activity of Dachaihu decoction as an example. J. Ethnopharmacol. 312, 116539 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"47257_CR55","doi-asserted-by":"publisher","first-page":"628671","DOI":"10.3389\/fphar.2021.628671","volume":"12","author":"L Ruiqi","year":"2021","unstructured":"Ruiqi, L. et al. Saikosaponin D inhibits peritoneal fibrosis in rats with renal failure by regulation of TGF\u03b21\/ BMP7 \/ Gremlin1\/ Smad pathway. Front. Pharmacol. 12, 628671 (2021).","journal-title":"Front. Pharmacol."},{"issue":"2","key":"47257_CR56","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3724\/abbs.2022132","volume":"55","author":"W Yang","year":"2022","unstructured":"Yang, W., Zhang, S., Li, T., Zhou, Z. & Pan, J. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-\u03b2\/Smad pathway. Acta Biochim. Biophys. Sin. (Shanghai) 55(2), 262\u2013273 (2022).","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"47257_CR57","doi-asserted-by":"publisher","first-page":"154901","DOI":"10.1016\/j.phymed.2023.154901","volume":"116","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy. Phytomedicine 116, 154901 (2023).","journal-title":"Phytomedicine"},{"issue":"2","key":"47257_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/jir.2023.0103","volume":"44","author":"I Zaporowska-Stachowiak","year":"2024","unstructured":"Zaporowska-Stachowiak, I. et al. Interleukin-6 family of cytokines in cancers. J. Interferon Cytokine Res. 44(2), 45\u201359 (2024).","journal-title":"J. Interferon Cytokine Res."},{"issue":"1","key":"47257_CR59","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s13659-024-00478-4","volume":"14","author":"C Cai","year":"2024","unstructured":"Cai, C. et al. Paeoniflorin mitigates insulin-like growth factor 1-induced lipogenesis and inflammation in human sebocytes by inhibiting the PI3K\/Akt\/FoxO1 and JAK2\/STAT3 signaling pathways. Nat. Prod. Bioprospect. 14(1), 56 (2024).","journal-title":"Nat. Prod. Bioprospect."},{"issue":"7718","key":"47257_CR60","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560(7718), 382\u2013386 (2018).","journal-title":"Nature"},{"issue":"11","key":"47257_CR61","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1245\/s10434-019-07431-7","volume":"26","author":"Y Fan","year":"2019","unstructured":"Fan, Y. et al. Exosomal PD-L1 retains immunosuppressive activity and is associated with gastric cancer prognosis. Ann. Surg. Oncol. 26(11), 3745\u20133755 (2019).","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"47257_CR62","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1158\/1078-0432.CCR-17-2664","volume":"24","author":"MN Theodoraki","year":"2018","unstructured":"Theodoraki, M. N., Yerneni, S. S., Hoffmann, T. K., Gooding, W. E. & Whiteside, T. L. Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients. Clin. Cancer Res. 24(4), 896\u2013905 (2018).","journal-title":"Clin. Cancer Res."},{"key":"47257_CR63","doi-asserted-by":"publisher","first-page":"119359","DOI":"10.1016\/j.lfs.2021.119359","volume":"279","author":"L Guo","year":"2021","unstructured":"Guo, L., Li, H., Fan, T., Ma, Y. & Wang, L. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma. Life Sci. 279, 119359 (2021).","journal-title":"Life Sci."},{"issue":"1","key":"47257_CR64","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41401-023-01158-8","volume":"45","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1\/PD-L1 signaling axis. Acta Pharmacol. Sin. 45(1), 193\u2013208 (2024).","journal-title":"Acta Pharmacol. Sin."},{"key":"47257_CR65","doi-asserted-by":"publisher","first-page":"115485","DOI":"10.1016\/j.jpba.2023.115485","volume":"233","author":"P Yin","year":"2023","unstructured":"Yin, P. et al. Pharmacokinetic analysis for simultaneous quantification of Saikosaponin A- paeoniflorin in normal and poststroke depression rats: A comparative study. J. Pharm. Biomed. Anal. 233, 115485 (2023).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"47257_CR66","doi-asserted-by":"publisher","first-page":"e24461","DOI":"10.1016\/j.heliyon.2024.e24461","volume":"10","author":"J Li","year":"2024","unstructured":"Li, J. et al. Paeoniflorin increases the anti-tumor efficacy of sorafenib in tumor-bearing mice with liver cancer via suppressing the NF-\u03bab\/PD-l1 axis. Heliyon 10(2), e24461 (2024).","journal-title":"Heliyon"},{"key":"47257_CR67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.intimp.2019.03.049","volume":"72","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y., Chen, X., Rao, X., Zheng, C. & Peng, X. Saikosaponin a ameliorates lipopolysaccharide and d\u2013galactosamine-induced liver injury via activating LXR\u03b1. Int. Immunopharmacol. 72, 131\u2013137 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"47257_CR68","first-page":"8479868","volume":"2021","author":"L Chen","year":"2021","unstructured":"Chen, L. et al. Paeoniflorin protects against ANIT-induced cholestatic liver injury in rats via the activation of SIRT1-FXR signaling pathway. Evid. Based Complement. Alternat Med. 2021, 8479868 (2021).","journal-title":"Evid. Based Complement. Alternat Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47257-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47257-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:02:51Z","timestamp":1780574571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47257-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47257"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47257-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Experimental Animal Ethics Committee of the Third People\u2019s Hospital of Shenzhen approved this study (2022\u2009\u2212\u2009107). All experiments were carried out in accordance with the relevant guidelines and regulations, and reported following the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17256"}}